Latest News About Humulin R Insulin 100 Units, 10Ml Vial

I don’t have live access to the latest headlines right now, but here’s what’s most relevant based on recent public notices:

• There have been official communications indicating discontinuation or phased withdrawal of Humulin R insulin vials in the U.K. and some regions, with end dates for specific vial formats (notably Humulin R 100 U/mL in 10 mL vials). Clinicians are advised not to initiate new patients on certain Humulin R vial formats and to consider switching appropriate patients to pen devices or alternative insulin products as part of a device/formulation transition.[1]

• For patients currently using Humulin R vials, guidance commonly recommends coordinating with healthcare providers to plan a transition to an equivalent insulin product or a pen-form where appropriate, to minimize disruption in glycemic control.[1]

• Availability varies by market; some suppliers still list Humulin R 100 U/mL in 10 mL vials from certain vendors, though stock and official recommendations may differ by country and health system.[2][5]

• Related context notes: Other sources show ongoing supply and alternatives such as Novolin R or other U-100 regular insulins with similar profiles, and they emphasize checking local formulary and patient-specific considerations before any switch.[3][7]

Illustrative example (practical takeaway):

• If you or someone you care for relies on Humulin R 100 U/mL in a 10 mL vial, contact the prescribing clinician or pharmacist to confirm current supply status in your area and to outline a transition plan (including potential pen options) to avoid gaps in glucose control.

If you’d like, I can narrow this down to your location (London) and pull the most current local guidance and supplier status, or help you compare Humulin R alternatives (e.g., Novolin R or rapid/regular-insulins in pen formats) to ease the transition.